Environment &
Food & Beverage
Cosmetics
Life Sciences
Metal & Mining Industry
Petrochemical & General Chemistry
Automotive Related & Interior Materials
InertSearch (Application Library)
Index
Application
LC
Document No. Index
LB601 - 700 of Application List
| No. | Description | Column |
|---|---|---|
| LB601 | Analysis of Proteins | MonoSelect C18 for HTS |
| LB602 | Analysis of Methylhippuric acids | InertSustain Cyano HP |
| LB603 | Analysis of Steroids | InertSustain Cyano HP |
| LB604 | Analysis of Antidepressants | InertSustain Cyano HP |
| LB605 | Analysis of Antihistamines | InertSustain Cyano HP |
| LB606 | Analysis of Antihistamines | InertSustain Cyano HP |
| LB607 | Analysis of Plant hormones | InertSustain Cyano |
| LB608 | Analysis of Citral | InertSustain Cyano |
| LB609 | Analysis of Chlorophenols | InertSustain Cyano |
| LB610 | Analysis of Nortriptyline | InertSustain Cyano |
| LB611 | Analysis of Sertraline | InertSustain Cyano |
| LB612 | Analysis of Tetracaine | InertSustain Cyano |
| LB613 | Analysis of Isopropylmethylphenol | InertSustain AQ-C18 |
| LB614 | Analysis of L-Ascorbic acid 2-glucoside | Inertsil ODS-HL |
| LB615 | Analysis of Cromolyn (Under the Condition of USP41-NF36, Cromolyn Sodium) | InertSustain C18 |
| LB616 | Analysis of Levocetirizine (Under the Condition of USP41-NF36, Levocetirizine Dihydrochloride) | Inertsil SIL-100A |
| LB617 | Analysis of Levocetirizine | Inertsil SIL-100A |
| LB618 | Analysis of Pregabalin (Under the Condition of USP41-NF36, Pregabalin) | Inertsil ODS-3 |
| LB619 | Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride) | InertSustain C8 |
| LB620 | Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Tablets) | InertSustain C18 |
| LB621 | Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) | InertSustain C18 |
| LB622 | Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) | InertSustain C18 |
| LB623 | Analysis of Etoposide phosphate (Under the Condition of draft for USP) | InertSustain Phenyl |
| LB624 | Analysis of Etoposide phosphate (Under the Condition of draft for USP) | InertSustain Phenyl |
| LB625 | Analysis of Prasugrel hydrochloride (Under the Condition of USP42-NF37) | InertSustainSwift C18 |
| LB626 | Analysis of Prasugrel hydrochloride | InertSustain C18 |
| LB627 | Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone and vinyl acetate) | Inertsil ODS-4 |
| LB628 | Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (7) 2-Pyrrolidone) | Inertsil ODS-3 |
| LB629 | Analysis of Telmisartan (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) | Inertsil C8-3 |
| LB630 | Analysis of Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) | Inertsil C8-3 |
| LB631 | Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) | Inertsil C8-3 |
| LB632 | Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) | Inertsil C8-3 |
| LB633 | Analysis of Rivaroxaban (Under the Condition of draft for USP) | InertSustainSwift C18 |
| LB634 | Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) | InertSustainSwift C18 |
| LB635 | Analysis of Levetiracetam (Under the Condition of draft for USP) | InertSustain AQ-C18 HP |
| LB636 | Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Tablets) | InertSustainSwift C18 |
| LB637 | Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Extended-Release Tablets) | InertSustain C8 |
| LB638 | Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) | InertSustain C18 |
| LB639 | Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) | InertSustainSwift C18 |
| LB640 | Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) | InertSustain C18 |
| LB641 | Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) | InertSustain C18 |
| LB642 | Analysis of Dipeptides | InertSustain Amide |
| LB643 | Analysis of Dipeptides | InertSustain Amide |
| LB644 | Analysis of Methylhippuric acids | InertSustain Amide |
| LB645 | Analysis of Glyphosate and Glufosinate | InertSustain Amide |
| LB646 | Analysis of Nucleotides and Nucleosides | InertSustain Amide |
| LB647 | Analysis of Nicotinamide Adenine Dinucleotide (NADH, NAD+) | InertSustain Amide |
| LB648 | Analysis of Nucleotide sugars | InertSustain Amide |
| LB649 | Analysis of ATP and its related compounds | InertSustain Amide |
| LB650 | Analysis of CTP and its related compounds | InertSustain Amide |
| LB651 | Analysis of GTP and its related compounds | InertSustain Amide |
| LB652 | Analysis of UTP and its related compounds | InertSustain Amide |
| LB653 | Analysis of Oligonucleotides | InertSustain Amide |
| LB654 | Analysis of Peptides | InertSustain Amide |
| LB655 | Analysis of Peptides | InertSustain C18 |
| LB656 | Analysis of Peptides | InertSustain AQ-C18 |
| LB657 | Analysis of Peptides | InertSustain PFP |
| LB658 | Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) | Inertsil ODS-HL |
| LB659 | Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) | Inertsil ODS-HL |
| LB660 | Analysis of Copovidone(Under the Condition of European Pharmacopoeia 10.0, Impurity A) | Inertsil ODS-4 |
| LB661 | Analysis of BSA | MonoSelect RP-mAb |
| LB662 | Analysis of HSA | MonoSelect RP-mAb |
| LB663 | Analysis of IgG | MonoSelect RP-mAb |
| LB664 | Analysis of Insulin | MonoSelect RP-mAb |
| LB665 | Analysis of Lysozyme | MonoSelect RP-mAb |
| LB666 | Analysis of Myoglobin | MonoSelect RP-mAb |
| LB667 | Analysis of Ribonuclease A | MonoSelect RP-mAb |
| LB668 | Analysis of Nitrosoamines (NDMA, NDEA) | InertSustain PFP |
| LB669 | Analysis of Rosuvastatin calcium (Under the condition of the Japanese Pharmacopoeia (JP) ) | InertSustainSwift C18 |
| LB670 | Analysis of Sucrose (Under the condition of the PDG (Pharmacopeial Discussion Group) Stage 2 Drafts) | InertSphere Sugar-2 |
| LB671 | Analysis of Sucrose (Under the condition of the PDG (Pharmacopeial Discussion Group) Stage 2 Drafts) | InertSphere Sugar-2 |
| LB672 | Analysis of Stearyl Glycyrrhetinate | InertSustainSwift C8 |
| LB673 | Analysis of Limonene | InertSustain C18 |
| LB674 | Analysis of β-Cryptoxanthin | Inertsil ODS-3 |
| LB675 | Analysis of Carotenoids | Inertsil ODS-P |
| LB676 | Analysis of Anticancer drug and related substances | InertSustain PFP HP |
| LB677 | Analysis of Zebularine and Gemcitabine | InertSustain C18 HP |
| LB678 | Analysis of Validamycin | InertSustain C18 HP |
| LB679 | Analysis of Cetylpyridinium chloride | InertSustain AX-C18 |
| LB680 | Analysis of bromate | InertSustain C18 |
| LB681 | Analysis of Moxifloxacin | InertSustain Phenylhexyl |
| LB682 | Analysis of Acetic acid and Acetic anhydride | InertSustainSwift C18 |
| LB683 | Analysis of Saccharin | Inertsil WP300 C18 |
| LB684 | Analysis of Saccharin Sodium Hydrate | Inertsil WP300 C18 |
| LB686 | Analysis of Chlorogenic acid | InertSustain AX-C18 |
| LB687 | Analysis of Ampicillin Hydrate | Inertsil ODS-4 |
| LB688 | Analysis of Red pepper extract | InertSustain C18 |
| LB689 | Analysis of Capsaicin in red pepper (InertSustain AQ-C18) | InertSustain AQ-C18 |
| LB690 | Analysis of Nitrosamines | InertSustain PFP |
| LB691 | Analysis of Nitrosamines | InertSustain PFP |
| LB692 | Analysis of Nitrosamines | InertSustain AQ-C18 |
| LB693 | Analysis of Preservatives and Sweetener | InertCore Plus C18 |
| LB694 | Analysis of Toluene and Toluene d8 | InertCore Plus C18 |
| LB695 | Analysis of acetic acid （USP） | InertSustainSwift C18 |
| LB696 | Analysis of Trifluoroacetic acid | InertSustain AQ-C18 |
| LB697 | Analysis of DNPH-formaldehyde and acetaldehyde | InertCore Plus C18 |
| LB698 | Analysis of Neomycin Sulfate (European Pharmacopoeia 11.0th Edition, Purity Test) | InertSustain C18 |
| LB699 | Analysis of Refined Glucose (Japanese Pharmacopoeia 18th Edition, Glucose, Assay) | InertSphere Sugar-2 |
| LB700 | Analysis of acetaminophen | InertSustain C18 |